Results of a study using an experimental aerosol insulin device suggest that diabetic patients with asthma may need to inhale more insulin to achieve similar glycemic control as their nonasthmatic counterparts.
The device, called the
AERx insulin Diabetes Management System (AERx iDMS; Aradigm, Hayward, Calif.),
is designed to deliver a controlled aerosol of liquid human insulin to the deep
lungs for systemic absorption.
To see if airflow
obstruction and other pathophysiological changes in patients with asthma alter
distribution and absorption of inhaled insulin, Dr. Robert R. Henry of the VA
San Diego Healthcare System in California and colleagues enrolled 17 asthmatic
and 28 nonasthmatic diabetics in a two-part, open-label trial. Patients were
excluded for a number of reasons, including treatment with oral, intravenous,
intra-articular, or intra-muscular corticosteroids within 12 weeks or inhaled
corticosteroids within 4 weeks.
In part one of the
study, researchers assessed insulin pharmacokinetics and pharmacodynamics by
having subjects inhale a single 1.57 mg (45 IU) dose of insulin on each of 2
dosing days. In part two of the study, they assessed the impact, if any, of
inhaled insulin on pulmonary function by having subjects inhale a larger dose of
insulin (4.7 mg [135 IU]).
Compared with
nonasthmatics, asthmatic subjects absorbed significantly less inhaled insulin
and, as a result, had less reduction in their blood glucose.
Inhaled insulin had no
impact on pulmonary function. Results showed no worsening of the patients'
hyper-reactivity airway state, wlth, with no clinically meaningful changes in
FEV1, FVC, and FEV1/FVC values.
"Many patients with diabetes are reluctant to initiate insulin therapy because of needle anxiety," Dr. Henry said. "The availability of a noninvasive insulin delivery system such as the AERx iDMS will likely result in the earlier institution of insulin therapy and improved patient compliance, both of which could have multiple beneficial effects in the short and long run."
Source: Diabetes In Control Dot
Com: Diabetes
Care 2003;26:764-769.
Home - Table of Contents - Donate Now - About Diabetes - Warning Signs - Complications - Screening Test - Diabetes Terms - Site Search - Meet Mr. Diabetes® - Wake Up And Walk® Tour - Latest News - Headlines & News Stories - Health & Fitness - About Us - FAQ - Research Form - - Message Board - Privacy Policy - Legal Notices - How to Contact Us - Comments form - Suggestion Form - Our E-Mail Addresses - Our Address and Phone Numbers - Links - Contact Us